CPI Aerostructures Inc: Form 10-Q for the period ended Mar 31, 2024
Filed with the SEC on May 15, 2024 and accepted by EDGAR at May 15, 2024, 17:28 ET.
Management's discussion and analysis
As filed, 19,108 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
The following discussion should be read in conjunction with the Company’s consolidated financial statements and notes thereto contained in this report.
Forward Looking Statements
When used in this Form 10-Q and in future filings by us with the Securities and Exchange Commission (the “SEC”), the words or phrases “will likely result,” “management expects” or “we expect,” “will continue,” “is anticipated,” “estimated” or similar expressions are intended to identify “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Readers are cautioned not to place undue reliance on any such forward-looking statements, each of which speaks only as of the date made. Such statements are subject to certain risks and uncertainties that could cause actual results to differ materially from historical earnings and those presently anticipated or projected. The risks are included in Part I, Item 1A – Risk Factors of our Annual Report on Form 10-K for the year ended December 31, 2023 (the “Form 10-K”). We have no obligation to publicly release the result of any revisions which may be made to any forward-looking statements to reflect anticipated or unanticipated events or circumstances occurring after the date of such statements.
Business Operations
We are engaged in the contract production of structural aircraft parts for fixed wing aircraft and helicopters in both the commercial and defense markets. We also have a strong and growing presence in the aerosystems sector of the market, with our production of various reconnaissance pod structures and fuel panel systems. Within the global aerostructure and aerosystem supply chain, we are either a Tier 1 supplier to aircraft original equipment manufacturers (“OEMs”) or a Tier 2 subcontractor to major Tier 1 manufacturers. We also are a prime contractor to the United States Department of Defense (“DOD”), primarily the United States Air Force (“USAF”). In conjunction with our assembly operations, we provide engineering, program management, supply chain management and kitting, and maintenance, repair and overhaul (“MRO”) services.
Recent Developments
None.
Backlog
We produce custom assemblies pursuant to long-term contracts and customer purchase orders. Funded backlog consists of aggregate funded values under such contracts and purchase orders, excluding the portion previously included in operating revenues pursuant to Accounting Standards Codification Topic 606 (“ASC 606”). Unfunded backlog is the estimated amount of future orders under the expected duration of the programs. Substantially all of our backlog is subject to termination at will and rescheduling, without significant penalty. Funds are often appropriated for programs or contracts on a yearly or quarterly basis, even though the contract may call for performance that is expected to take a number of years. Therefore, our funded backlog does not include the full value of our contracts.
Our total backlog as of March 31, 2024 and December 31, 2023 was as follows:
| Backlog (Total) | March 31, 2024 | December 31, 2023 |
|---|---|---|
| Funded | $103,597,000 | $118,218,000 |
| Unfunded | 406,771,000 | 395,133,000 |
| Total | $510,368,000 | $513,351,000 |
Approximately 96% of the total amount of our backlog at March 31, 2024 was attributable to government and military contractor contracts. Our backlog attributable to government contracts at March 31, 2024 and December 31, 2023 was as follows:
| Backlog (Government) | March 31, 2024 | December 31, 2023 |
|---|---|---|
| Funded | $99,242,000 | $115,681,000 |
| Unfunded | 390,571,000 | 383,574,000 |
| Total | $489,813,000 | $499,255,000 |
Our backlog attributable to commercial contracts at March 31, 2024 and December 31, 2023 was as follows:
| Backlog (Commercial) | March 31, 2024 | December 31, 2023 |
|---|---|---|
| Funded | $4,355,000 | $2,537,000 |
| Unfunded | 16,200,000 | 11,559,000 |
| Total | $20,555,000 | $14,096,000 |
14
The total backlog at March 31, 2024 is primarily comprised of long-term programs with Raytheon (Next Generation Jammer (“NGJ”) – Mid Band Pods and Advanced Tactical Pods), Collins Aerospace (Airborne Reconnaissance Pods), USAF (T-38 Classic Structural Modification Kits), Lockheed Martin (F-16 RI/DCC’s), Raytheon (B-52 Radar Racks), Embraer (Phenom 300 Engine Inlets), Sikorsky (CH-53K Welded Tubes), Sikorsky (UH-60 BLACKHAWK Gunner Windows), Boeing (A-10 Main Landing Gear Pods) and Sikorsky (UH-60 BLACKHAWK Stabilator MRO).
The funded backlog at March 31, 2024 is primarily from purchase orders under long-term contracts with Raytheon (NGJ – Mid Band Pods), USAF (T-38 Classic Structural Modification Kits), Collins Aerospace (Airborne Reconnaissance Pods), Boeing (A-10 Main Landing Gear Pods), Sikorsky (CH-53K Welded Tubes), Sikorsky (UH-60 BLACKHAWK Gunner Windows), Lockheed Martin (F-16 RI/DCC’s), Embraer (Phenom 300 Engine Inlets) and Raytheon (Advanced Tactical Pods).
Critical Accounting Estimates
We make a number of significant estimates, assumptions and judgments in the preparation of our financial statements. See Management’s Discussion and Analysis of Financial Condition and Results of Operations in the Form 10-K, for a discussion of our critical accounting estimates. There have been no significant changes to the application of our critical accounting estimates during the quarter ended March 31, 2024.
Results of Operations
Revenue
Total Revenue for the three months ended March 31, 2024 was $19,081,143 compared to $22,016,668 for the same period last year, a decrease of $2,935,525 or 13.3%, driven primarily by decreases in our Raytheon NGJ – Mid Band Pods, Sikorsky UH-60 BLACKHAWK Hover Infrared Suppression System (“HIRSS”) Module Assemblies and Lockheed Martin F-16 Rudder Island/Drag Chute Canisters (RI/DCC’s) programs, partly offset by increases in our USAF T-38 Pacer Classic Structural Modification Kits and Collins Aerospace Pods programs.
Revenue from military subcontracts was $15,001,768 for the three months ended March 31, 2024 compared to $18,672,893 for the three months ended March 31, 2023, a decrease of $3,671,125 or 19.7%, driven primarily by decreases in our Raytheon NGJ – Mid Band Pods, Sikorsky UH-60 BLACKHAWK HIRSS Module Assemblies and Lockheed Martin F-16 RI/DCC’s programs, partly offset by increases in our Collins Aerospace Pods programs.
Revenue from government military contracts was $2,781,881for the three months ended March 31, 2024 compared to $1,408,034 for the three months ended March 31, 2023, an increase of $1,373,847 or 97.6%, primarily on an increase in our USAF T-38 Pacer Classic Structural Modification Kits program.
Revenue from commercial subcontracts was $1,297,494 for the three months ended March 31, 2024 compared to $1,935,741 for the three months ended March 31, 2023, a decrease of $638,247 or 33.0%, primarily on a decrease in our Embraer Phenom Engine Inlet Assemblies program.
Cost of Sales
Total Cost of Sales for the three months ended March 31, 2024 and 2023 was $15,527,394 and $17,354,152, respectively, a decrease of $1,826,758 or 10.5%.
The components of the cost of sales were as follows:
| Three months ended March 31, 2024 | March 31, 2023 | |
|---|---|---|
| Procurement | $9,365,019 | $11,488,091 |
| Labor | 1,797,790 | 1,854,863 |
| Factory overhead | 4,267,095 | 3,779,878 |
| Other cost of sales | 97,490 | 231,320 |
| Cost of sales | $15,527,394 | $17,354,152 |
Procurement for the three months ended March 31, 2024 was $9,365,019 compared to $11,488,091 for the three months ended March 31, 2023, a decrease of $2,123,072 or 18.5%, driven primarily by decreases in our Raytheon NGJ – Mid Band Pods, Sikorsky UH-60 BLACKHAWK HIRSS Module Assemblies and Lockheed Martin F-16 RI/DCC’s programs, partly offset by increases in our Collins Aerospace Pods programs.
Labor costs for the three months ended March 31, 2024 were $1,797,790 compared to $1,854,863 for the three months ended March 31, 2023, a decrease of $57,073 or 3.1%.
Factory overhead for the three months ended March 31, 2024 was $4,267,095 compared to $3,779,878 for the three months ended March 31, 2023, an increase of $487,217 or 12.9%. This increase was primarily the result of higher salary and benefit costs.
Other cost of sales relates to items that can increase or decrease cost of sales such as changes in inventory reserves, changes in loss contract provisions, absorption variances and direct charges to cost of sales. Other cost of sales for the three months ended March 31, 2024 was $97,490 compared to a $231,320 for the three months ended March 31, 2023, a decrease of $133,830 or 57.9%. The decrease is primarily the result of a higher level of loss contract reserve reduction for the for the three months ended March 31, 2024 as compared to the three months ended March 31, 2023.
Gross Profit
Gross profit and gross profit percentage (“gross margin”) for the three months ended March 31, 2024 was $3,553,749 and 18.6%, respectively, compared to $4,662,516 and 21.2%, respectively, for the three months ended March 31, 2023, a decrease of $1,108,767, or 23.8%, and 260 basis points, respectively, for the reasons noted above and an unfavorable year-over-year mix.
Favorable/Unfavorable Adjustments to Gross Profit
During the three months ended March 31, 2024 and 2023, circumstances required that we make changes in estimates to various contracts. Such changes in estimates resulted in changes in total gross profit as follows:
| Three months ended March 31, 2024 | March 31, 2023 | |
|---|---|---|
| Favorable adjustments | $912,487 | $825,981 |
| Unfavorable adjustments | (2,085,348) | (1,546,986) |
| Net adjustments | $(1,172,861) | $(721,005) |
Selling, General and Administrative Expenses
Selling, general and administrative expenses for the three months ended March 31, 2024 were $2,713,904 compared to $2,869,058 for the three months ended March 31, 2023, a decrease of $155,154 or 5.4%. The decrease was primarily the result of lower personnel related expenses.
Interest expense
Interest expense for the three months ended March 31, 2024 was $632,135, compared to $610,896 for the three months ended March 31, 2023, an increase of $21,239 or 3.5%. The increase was the result of higher year-over-year interest rates charged on our outstanding debt under the Credit Agreement, partially offset by a year-over-year decrease in the amount of our outstanding debt under the Credit Agreement.
Income Before Provision for Income Taxes
Income before provision for income taxes for the three months ended March 31, 2024 was $207,710 compared to $1,182,562 for the three months ended March 31, 2023, a decrease of $974,852 or 82.4% for the reasons noted above.
Provision for Income Taxes
Provision for income taxes for the three months ended March 31, 2024 was $39,472 compared to $199,257 for the three months ended March 31, 2023, a decrease of $159,785. The decrease in the provision for income tax is primarily the result of the Company’s lower year over year pre-tax book income.
The effective income tax rate for the three months ended March 31, 2024 is 19%. The difference between the effective income tax rate for the three months ended March 31, 2024 and the statutory income tax rate of 21% for the three months ended March 31, 2024 is primarily due estimated R&D credit, state income taxes and permanent tax differences.
Net Income and Earnings per Share
Net income for the three months ended March 31, 2024 was $168,238 compared to $983,305 for the three months ended March 31, 2023, a decrease of $815,067 or 82.9% for the reasons noted above.
Basic and diluted income per share for the three months ended March 31, 2024 of $0.01 compared to $0.08 for the three months ended March 31, 2023, a decrease of $0.07, or 87.5%.
Basic and diluted income per share for the three months ended March 31, 2024 was calculated using 12,486,889 and 12,680,584 weighted average basic and diluted shares outstanding, respectively, as compared to 12,520,189 and 12,608,189 weighted average basic and diluted shares outstanding, respectively, for the three months ended March 31, 2023.
Liquidity and Capital Resources
General
At March 31, 2024, we had working capital of $15,166,678 compared to $15,402,381 at December 31, 2023, a decrease of $235,703 or 1.5%. The decrease was driven primarily by higher accounts payable, partly offset by higher accounts receivable and lower current portion of long-term debt and loss reserves.
Cash Flow
A large portion of our cash flow is used to pay for materials and processing costs associated with contracts that are in process and which do not provide for progress payments. Costs and related earnings for which we do not bill on a progress basis, and which, as a result, we bill upon shipment of products, are components of contract assets on our consolidated balance sheets and represent the aggregate costs and related earnings for uncompleted contracts for which the customer has not yet been billed. These costs and earnings are recovered upon shipment of products and presentation of billings in accordance with contract terms.
Because ASC 606 requires us to use estimates in determining revenue, costs and profits and in assigning the amounts to accounting periods, there can be a significant disparity between earnings (both for accounting and tax purposes) as reported and actual cash that we receive during any reporting period. Accordingly, it is possible that we may have a shortfall in our cash flow and may need to borrow money or take steps to defer cash outflows until the reported earnings materialize into actual cash receipts.
Some of our programs require us to expend up-front costs that may have to be amortized over a portion of production units. In the case of significant program delays and/or program cancellations, we could experience margin degradation, which may be material for costs that are not recoverable. Such charges and the loss of up-front costs could have a material impact on our liquidity and results of operations.
We continuously work to improve our payment terms from our customers, including accelerated progress payment arrangements, as well as exploring alternate funding sources.
At March 31, 2024, we had cash of $3,018,068 compared to $5,094,794 at December 31, 2023, a decrease of $2,076,726 or 40.8%. This decrease was primarily the result of repayment of debt and cash flow used in operations.
Bank Credit Facilities
On March 24, 2016, the Company entered into an Amended and Restated Credit Agreement with the lenders named therein and BankUnited N.A. as Sole Arranger, Agent and Collateral Agent (as amended from time to time, the “Credit Agreement” or the “BankUnited Facility”). The Credit Agreement originally provided for a revolving credit loan commitment of $30 million (the “Revolving Loan”) and a $10 million term loan (“Term Loan”). The Revolving Loan bears interest at a rate as defined in the Credit Agreement.
On February 20, 2024, the Company entered into a Thirteenth Amendment to the Credit Agreement (the “Thirteenth Amendment”). Under the Thirteenth Amendment, the parties amended the Credit Agreement by (a) extending the maturity date of the Company’s existing revolving line of credit to August 31, 2025; and (b) setting the aggregate maximum principal amount of all revolving line of credit loans to $19,800,000 from January 1, 2024 through March 31, 2024, $19,080,000 from April 1, 2024 through June 30, 2024, $18,360,000 from July 1, 2024 through September 30, 2024, $17,640,000 from October 1, 2024 through December 31, 2024, $16,920,000 from January 1, 2025 through March 31, 2025, $16,200,000 from April 1, 2025 through June 30, 2025 and $15,480,000 thereafter, and for payments to be made by the Company to comply therewith (if any such payments are necessary), on the first day of each such period.
The Credit Agreement, as amended, requires us to maintain the following financial covenants: (a) minimum debt service coverage ratio of no less than 1.5 to 1.0 for trailing four fiscal quarter periods; (b) maximum leverage ratio of no less than 4.0 to 1.0 for trailing four fiscal quarter periods; (c) minimum net income after taxes as of the end of each fiscal quarter being no less than $1.00; and (d) a minimum adjusted EBITDA at the end of each fiscal quarter of no less than $1.0 million. The additional principal payments, increase in interest and the Amendment Fee provided for in the Eighth Amendment (entered into on October 28, 2021) and Ninth Amendment to the Credit Agreement (entered into on April 12, 2022) are excluded for purposes of calculating compliance with each of the financial covenants.
The BankUnited Facility is secured by all of the Company’s assets and the Revolving Loan bears interest at the Prime Rate + 3.50%. The Prime Rate was 8.50% as of March 31, 2024 and as such, the Company’s interest rate on the Revolving Loan was 12.00% as of March 31, 2024.
As of March 31, 2024 and December 31, 2023, the Company had $19,080,000 and $20,040,000 outstanding under the Revolving Loan, respectively.
There is currently no availability for borrowings under the Revolving Loan and the Company finances its operations from internally generated cash flow.
Liquidity
We believe that our existing resources as of March 31, 2024 will be sufficient to meet our current working capital needs for at least the next 12 months from the date of issuance of our consolidated financial statements. However, our working capital requirements can vary significantly, depending in part on the timing of new program awards and the payment terms with our customers and suppliers. If our working capital needs exceed our cash flows from operations, we would look to our cash balances and availability for borrowings under our borrowing arrangement to satisfy those needs, as well as potential sources of additional capital, which may not be available on satisfactory terms and in adequate amounts, if at all.
Contractual Obligations
For information concerning our contractual obligations, see Contractual Obligations under Item 7 of Management’s Discussion and Analysis of Financial Condition and Results of Operations of our Annual Report on Form 10-K for the year ended December 31, 2023.
Inflation
Inflation historically has not had a material effect on our operations, although the current inflationary environment in the U.S., and its impact on interest rates, the supply chain, the labor market and general economic conditions, are factors that the Company actively monitors in an attempt to mitigate and manage potential negative impacts on and risks faced by the Company. The majority of the Company’s long term contracts with its customers reflect fixed pricing and its long term contracts with its suppliers reflect fixed pricing. When bidding for work, the Company takes inflation risk and supply side pricing risk into account in its proposals.
Controls and procedures
As filed, 3,393 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Management is responsible for establishing and maintaining adequate internal control over financial reporting. Internal control over financial reporting, as defined in Exchange Act Rules 13a-15(f) and 15d-15(f), is a process designed by, or under the supervision of, our principal executive and principal financial officers and effected by our board of directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. GAAP and includes those policies and procedures that:
- pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our assets;
- provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with U.S. GAAP, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors; and
- provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on our consolidated financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
Management conducted an evaluation of the effectiveness of internal control over financial reporting for the twelve months ended December 31, 2023 based on criteria established in Internal Control- Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”). In connection with this evaluation, management identified a deficiency that constituted a material weakness in our internal control over financial reporting as of December 31, 2023, pertaining to income tax accounting. For more information on this deficiency, see Item 9A. Controls and Procedures, included in our Annual Report on Form 10-K. Based on management’s evaluation of internal control over financial reporting for the twelve months ended December 31, 2023, and as of March 31, 2024, our disclosure controls and procedures were not effective as of March 31, 2024 due to the aforementioned material weakness pertaining to income tax accounting.
A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company’s annual or interim consolidated financial statements will not be prevented or detected on a timely basis.
The Company has begun to develop new controls designed to remediate the aforementioned 2023 material weakness pertaining to income tax accounting, which the Company intends to implement during 2024.
Changes in Internal Control Over Financial Reporting
There were no changes in our internal control over financial reporting during the quarter ended March 31, 2024 that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Risk factors
As filed, 342 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
“Item 1A. Risk Factors” of our Annual Report on Form 10-K for the year ended December 31, 2023, includes a discussion of significant factors known to us that could materially adversely affect our business, financial condition, or results of operations. There have been no material changes from the risk factors disclosed in the Annual Report.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2024-01-01 to 2024-03-31 | $19.1m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2024-01-01 to 2024-03-31 | $15.5m | us-gaap:CostOfRevenue |
| Gross profit | 3 months2024-01-01 to 2024-03-31 | $3.6m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months2024-01-01 to 2024-03-31 | $2.7m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2024-01-01 to 2024-03-31 | $839.8k | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2024-01-01 to 2024-03-31 | $632.1k | us-gaap:InterestExpense |
| Income tax | 3 months2024-01-01 to 2024-03-31 | $39.5k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2024-01-01 to 2024-03-31 | $168.2k | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2024-01-01 to 2024-03-31 | $0.01 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2024-01-01 to 2024-03-31 | $0.01 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2024-01-01 to 2024-03-31 | 12,680,584 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2024-01-01 to 2024-03-31 | −$960.5k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2024-01-01 to 2024-03-31 | $46.8k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2024-03-31 | $3.0m | us-gaap:Cash |
| Current assets | At period end2024-03-31 | $43.9m | us-gaap:AssetsCurrent |
| Total assets | At period end2024-03-31 | $70.8m | us-gaap:Assets |
| Current liabilities | At period end2024-03-31 | $28.7m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2024-03-31 | $48.2m | us-gaap:Liabilities |
| Shareholders' equity | At period end2024-03-31 | $22.5m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001999371-24-006169. Last ingested by Listed: Oct 24, 2026, 14:59 ET. Listed shows no prices and gives no investment advice.